Sandhoff Disease Clinical Trial
Official title:
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
The goal of this research study is to establish chimerism and avoid graft-versus-host-disease (GVHD) in patients with inherited metabolic disorders.
The objective for the study is to establish chimerism following reduced intensity conditioning with no grade III/IV GVHD. The primary endpoint we will follow is production of the missing enzyme at ≥ 10% of the normal level at day 180 post-transplant in > 90% of patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02254863 -
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
|
Phase 1 | |
Recruiting |
NCT04624789 -
Registry Gangliosidoses
|
||
Completed |
NCT03759665 -
N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)
|
Phase 2 | |
Active, not recruiting |
NCT04221451 -
A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2
|
Phase 3 | |
Completed |
NCT04470713 -
Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2
|
||
Completed |
NCT00672022 -
Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
|
Phase 3 | |
Completed |
NCT00176904 -
Stem Cell Transplant for Inborn Errors of Metabolism
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04669535 -
A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease
|
Phase 1 | |
Recruiting |
NCT03333200 -
Longitudinal Study of Neurodegenerative Disorders
|
||
Active, not recruiting |
NCT05109793 -
GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
|
||
Terminated |
NCT02030015 -
Synergistic Enteral Regimen for Treatment of the Gangliosidoses
|
Phase 4 | |
Recruiting |
NCT00668187 -
A Natural History Study of the Gangliosidoses
|
||
Completed |
NCT01869270 -
Gene Therapy for Tay-Sachs Disease
|
N/A | |
Completed |
NCT01102686 -
Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)
|
Phase 1/Phase 2 |